LEVETIRACETAM DEXCEL 250

Nchi: Israeli

Lugha: Kiingereza

Chanzo: Ministry of Health

Viambatanisho vya kazi:

LEVETIRACETAM

Inapatikana kutoka:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC kanuni:

N03AX14

Dawa fomu:

TABLETS

Tungo:

LEVETIRACETAM 250 MG

Njia ya uendeshaji:

PER OS

Dawa ya aina:

Required

Viwandani na:

DEXCEL LTD, ISRAEL

Kundi la matibabu:

LEVETIRACETAM

Eneo la matibabu:

LEVETIRACETAM

Matibabu dalili:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Idhini ya tarehe:

2018-03-31